Aurora SpineASAPF +10.27%40 Receivables Turnover is 1.41 as of Mar. 2026. GuruFocus rates ASAPF with a GF Score™ of 40/100 and a GF Value™ of $0.22 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 812 Medical Devices & Instruments companies, Aurora Spine ranks better than 51.72% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Aurora Spine's Revenue for the
three
months ended in Mar. 2026 was $4.44 Mil. Aurora Spine's average Accounts Receivable for the
three
months ended in Mar. 2026 was $3.15 Mil.
Hence, Aurora Spine's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.41.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Aurora Spine Receivables Turnover Related Terms
Aurora Spine Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Aurora Spine's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASAPF vs ABT, SYK, MDT: Receivables Turnover Comparison
For the Medical Devices subindustry, Aurora Spine's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aurora Spine Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aurora Spine's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Aurora Spine's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aurora Spine (ASAPF) has a Receivables Turnover of 1.41 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Aurora Spine and its competitors. According to the industry distribution chart, Aurora Spine ranks #392 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 48.3%.
Is Aurora Spine's Receivables Turnover too high?
Aurora Spine's current Receivables Turnover is 1.41. The Medical Devices & Instruments industry median Receivables Turnover is 5.57. Aurora Spine's value of 1.41 is 74.7% below this industry median. Based on the distribution chart, Aurora Spine ranks #392 out of 812 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Aurora Spine has a GF Score™ of 40/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aurora Spine's Receivables Turnover compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Aurora Spine ranks #392 out of 812 companies for Receivables Turnover. This puts Aurora Spine in the upper half of its industry. The industry median Receivables Turnover is 5.57. Aurora Spine's value of 1.41 is 74.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.57, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aurora Spine's current Receivables Turnover of 1.41 is 74.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Aurora Spine and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aurora Spine's current Receivables Turnover is 1.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurora Spine stock overvalued right now?
Based on GuruFocus' analysis, Aurora Spine (ASAPF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.22, compared to a current price of $0.18 — trading 20.5% below its estimated fair value. The current Receivables Turnover is 1.41 and 74.7% below the Medical Devices & Instruments industry median of 5.57. Aurora Spine's overall GF Score™ is 40/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Aurora Spine (ASAPF), the current Receivables Turnover is 1.41 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aurora Spine (ASAPF) Overvalued in 2026?
Based on GuruFocus' analysis, Aurora Spine stock appears to be undervalued.
The current stock price of $0.18 is trading 20.5% below its estimated GF Value™ of $0.22.
GuruFocus considers Aurora Spine to be Modestly Undervalued.
Key valuation signals for ASAPF:
Receivables Turnover: 1.41
GF Value™: $0.22 vs. price of $0.18 (20.5% below fair value)
Industry Position: 74.7% below the Medical Devices & Instruments median (#392 of 812)
No single metric tells the full story. See the ASAPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aurora Spine Corp is engaged in the development, manufacture, and sale of minimally invasive, interspinous fusion systems and devices. These 510K and patent protected medical devices improve patient outcomes in the area of spine and sacroiliac joint surgical procedures. The company is focused on bringing new solutions to the spinal implant market through a series of minimally invasive, regenerative spinal implant technologies.
40GF Score
Get the complete analysis for ASAPF
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASAPF has been successfully added to your 
